Sheldon Inwentash

CA., CPA., LL.D

Sheldon Inwentash, is chairman and chief executive officer of ThreeD Capital Inc., a Toronto-based venture capital firm specializing in investments in junior resources, technology and biotechnology. Sheldon has more than 30 years of investing experience and has been instrumental in raising $15 billion for his portfolio of companies over the last 15 years.

Paul Rosen

LL.B

Paul Rosen has become of Canada’s most active and diversified investors in the emerging cannabis industry. He is the founder and Chairman of BreakWater Venture Capital, a private venture capital fund based in Toronto. Paul Rosen was a co-founder of PharmaCan Capital (now d.b.a. The Cronos Group), a publically traded merchant bank focused on Canada’s medical marijuana industry ( MJN.V).

Dr. Yuri Lawryshyn

PhD, MBA

Yuri has worked in a number of industries in R&D, management, marketing and strategy. In 2007, he joined the faculty of Engineering at the UofToronto, specializing in applying financial engineering principles for the valuation of real assets/projects, with emphasis in the development of practical approaches to real options.

Alan Friedman

BCOMM, BProc Law

Alan is the founder and CEO of Rivonia Capital Inc., a Canadian finance and capital markets advisory firm. He is also a co-founder of several publicly traded companies across diversified industries. Alan co-founded the capital pool corporation, which took the Cronos Group public onto the TSXV, and is currently a director on its board.

Alex Chan

R.Ph., B.S.Phm., M.B.A.

Alex is a licensed pharmacist and a graduate of the Faculty of Pharmacy, University of Toronto. He has worked for over 30 years in practically all aspects of pharmacy field. He is the owner of Solara Pharmacy with two locations that serve Etobicoke and Thornhill. Both pharmacy sites provide vaccinations and addiction treatment. In addition, he is a managing partner of Enhanced Care Medical Services, a preferred provider of physician clinical services to McKesson Canada.